Company News

Share this article:
IMS Health launched Ask IMS, a web-based service offering low-cost, entry level strategic market intelligence to newer biopharma firms and startups. The offering, says IMS, provides country specific data on sales and prescribing trends, primary disease treatments and promotion activities in specific markets.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

FDA approves Glaxo's GLP-1

Type-2 diabetes injection Tanzeum, also known as albiglutide, scored the approval Tuesday.

Insurers get personal to nip costs

Healthcare insurers seek to curb diabetes costs with interventions that may include house calls.

Novartis dials down RNA research

The drugmaker says the therapeutic approach has a narrow treatment potential.